Clinical Trial Update: Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating alpha/beta T cell receptor alpha/beta-depleted hematopoietic cell transplantation in inherited bone marrow failure d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Bone Marrow Failure
• Dyskeratosis Congenita
• Fanconi Anemia
• Myelodysplastic Syndromes
• Telomere Biology Disorders

Drugs mentioned

• Alpha/Beta T cell receptor alpha/beta-depleted hematopoietic cell transplantation

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Fanconi Anemia, Severe Aplastic Anemia | Phase 2 | Status: RECRUITING